BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20634541)

  • 1. A method to assess the quality of studies that examine the toxicity of engineered nanomaterials.
    Card JW; Magnuson BA
    Int J Toxicol; 2010 Jul; 29(4):402-10. PubMed ID: 20634541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of information in nanomaterial safety data sheets and development of international standard for guidance on preparation of nanomaterial safety data sheets.
    Lee JH; Kuk WK; Kwon M; Lee JH; Lee KS; Yu IJ
    Nanotoxicology; 2013 May; 7(3):338-45. PubMed ID: 22263625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward.
    Lai DY
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):1-15. PubMed ID: 21965171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity.
    Fako VE; Furgeson DY
    Adv Drug Deliv Rev; 2009 Jun; 61(6):478-86. PubMed ID: 19389433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.
    Murdock RC; Braydich-Stolle L; Schrand AM; Schlager JJ; Hussain SM
    Toxicol Sci; 2008 Feb; 101(2):239-53. PubMed ID: 17872897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials.
    Card JW; Jonaitis TS; Tafazoli S; Magnuson BA
    Crit Rev Toxicol; 2011 Jan; 41(1):22-49. PubMed ID: 21077788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterial cell interactions: are current in vitro tests reliable?
    Hirsch C; Roesslein M; Krug HF; Wick P
    Nanomedicine (Lond); 2011 Jul; 6(5):837-47. PubMed ID: 21793675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A weight of evidence approach for hazard screening of engineered nanomaterials.
    Hristozov DR; Zabeo A; Foran C; Isigonis P; Critto A; Marcomini A; Linkov I
    Nanotoxicology; 2014 Feb; 8(1):72-87. PubMed ID: 23153309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotoxicology: the molecular science point of view.
    Pumera M
    Chem Asian J; 2011 Feb; 6(2):340-8. PubMed ID: 20725923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological aspects for nanomaterial in humans.
    Dusinska M; Magdolenova Z; Fjellsbø LM
    Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation.
    Powers KW; Brown SC; Krishna VB; Wasdo SC; Moudgil BM; Roberts SM
    Toxicol Sci; 2006 Apr; 90(2):296-303. PubMed ID: 16407094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells.
    Palomäki J; Karisola P; Pylkkänen L; Savolainen K; Alenius H
    Toxicology; 2010 Jan; 267(1-3):125-31. PubMed ID: 19897006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The primacy of physicochemical characterization of nanomaterials for reliable toxicity assessment: a review of the zebrafish nanotoxicology model.
    Bohnsack JP; Assemi S; Miller JD; Furgeson DY
    Methods Mol Biol; 2012; 926():261-316. PubMed ID: 22975971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials--part A.
    Methner M; Hodson L; Geraci C
    J Occup Environ Hyg; 2010 Mar; 7(3):127-32. PubMed ID: 20017054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology safety concerns revisited.
    Stern ST; McNeil SE
    Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotoxicity: the growing need for in vivo study.
    Fischer HC; Chan WC
    Curr Opin Biotechnol; 2007 Dec; 18(6):565-71. PubMed ID: 18160274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.